The LaNBDA (Laboratory of Nano and Biotechnology for Development in Advances) explores microfluidics as a multidisciplinary platform for biomedical and pharmaceutical applications. LaNBDA develops processes and products that leverage microscale fluid manipulation to synthesize nanoparticles, nanoaggregates, and microgels for the delivery of genes, drugs, and cells. The lab also advances microphysiological systems that mimic tissues and organs, enabling innovative models for testing therapeutic strategies. With over 14 years of expertise, LaNBDA bridges fundamental research and applied science to contribute to human and animal health.
To contribute to the training of researchers and future educators, enabling them to become agents of transformation in our society, expanding knowledge and developing new technologies in the fields of nano & biotechnology.
Engage in the development of cutting-edge technologies in the fields of nano & biotechnology, with applications in health and food industries;
Create a collaborative work environment that fosters professionals with critical thinking, solid technical foundations, and the ability to work in interdisciplinary teams.
Overview of LaNBDA
Design and fabrication of nanoparticles and nanoaggregates for drug and gene delivery
Development of microgels and structured biomaterials using microfluidics
Engineering of microphysiological systems to model tissues and organs
Microencapsulation and controlled release strategie
Translational approaches in biomedical and pharmaceutical research
Our work integrates materials science, bioengineering, nanotechnology, and pharmaceutical sciences to address complex biological challenges.
Droplet-based microfluidics
Nanoparticle and nanoaggregate engineering
Microgel and hydrogel structuring
Core–shell microstructures and microfibers
Microphysiological systems and tissue modeling platforms
2 Postdoctoral Associate
8 Ph. D. Students
5 Master’s students
3 Undergraduate Students